中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2015年
13期
11-12
,共2页
孔令华%贾彦丽%樊建平%赵华
孔令華%賈彥麗%樊建平%趙華
공령화%가언려%번건평%조화
卒中后抑郁%黛力新%神经康复
卒中後抑鬱%黛力新%神經康複
졸중후억욱%대력신%신경강복
Post stroke depression%Dailixin%Neurological rehabilitation
目的：观察黛力新与舍曲林联合应用对重度卒中后抑郁(post stroke depression，PSD)患者的临床疗效。方法：选择2013年1月-2014年10月笔者所在医院神经内科收治的符合重度卒中后抑郁的患者86例，按照随机数字表法分为治疗组与对照组。治疗组给予黛力新、舍曲林联合抗抑郁治疗，对照组仅给予黛力新治疗。访视治疗6个月，对治疗前，治疗1、3、6个月根据SDS抑郁评分量表进行计分。结果：治疗组患者计分改善情况明显优于对照组，差异有统计学意义(P<0.05)。结论：对重度卒中后抑郁患者，可考虑黛力新与舍曲林联合抗抑郁治疗。
目的：觀察黛力新與捨麯林聯閤應用對重度卒中後抑鬱(post stroke depression，PSD)患者的臨床療效。方法：選擇2013年1月-2014年10月筆者所在醫院神經內科收治的符閤重度卒中後抑鬱的患者86例，按照隨機數字錶法分為治療組與對照組。治療組給予黛力新、捨麯林聯閤抗抑鬱治療，對照組僅給予黛力新治療。訪視治療6箇月，對治療前，治療1、3、6箇月根據SDS抑鬱評分量錶進行計分。結果：治療組患者計分改善情況明顯優于對照組，差異有統計學意義(P<0.05)。結論：對重度卒中後抑鬱患者，可攷慮黛力新與捨麯林聯閤抗抑鬱治療。
목적：관찰대력신여사곡림연합응용대중도졸중후억욱(post stroke depression，PSD)환자적림상료효。방법：선택2013년1월-2014년10월필자소재의원신경내과수치적부합중도졸중후억욱적환자86례，안조수궤수자표법분위치료조여대조조。치료조급여대력신、사곡림연합항억욱치료，대조조부급여대력신치료。방시치료6개월，대치료전，치료1、3、6개월근거SDS억욱평분량표진행계분。결과：치료조환자계분개선정황명현우우대조조，차이유통계학의의(P<0.05)。결론：대중도졸중후억욱환자，가고필대력신여사곡림연합항억욱치료。
Objective:To observe the clinical effect of Deanxit combined with Sertraline on patients with severe post stroke depression(PSD). Method:86 cases with severe PSD in neurology of our hospital from January 2013 to October 2014 were randomly divided into two groups.The treatment group was given Deanxit combined with Sertraline for antidepressant treatment,while the control group was only given Deanxit.Visit 6 months,the SDS depression rating scale were assessed before and after one month,three months and six months treatment.Result:The treatment group was better than the control group,there was statistical significance(P<0.05).Conclusion:Deanxit combined with Sertraline for antidepressant treatment are considerable on patients with severe PSD.
